neurodegenerative disease
Synaps Dx Closes $10M Series A Round to Speed Commercialization of Alzheimer's Disease Test
The firm said the test has 95 percent sensitivity and specificity for diagnosing Alzheimer's disease based on autopsy-validated clinical data collected over many years.
Valted Seq Lands Exclusive Rights to Evaluate Johns Hopkins Neurodegenerative Disease Dx Assays
The biomarker assays could one day be used as companion diagnostics for new treatments of Parkinson's and related diseases.
Invitae, Passage Bio Collaborate on GM1 Genetic Testing, Clinical Trial Education
The firms said they are collaborating to facilitate genetic testing to support early diagnosis of GM1, a rare monogenic recessive lysosomal storage disease.
Bio-Techne, Uman Diagnostics Ink License, Supply Agreement for Neurofilament Light Assay
The firms said that Bio-Techne's Ella platform provides the sensitivity needed to provide analysis of the Nf-L biomarker for neurodegenerative diseases.
Quanterix to Acquire UmanDiagnostics for $22.5M
Quanterix said that the acquisition will secure the supply of neurofilament light antibodies that are critical to its Simoa assays and services.